Archive

Karl A. Mulligan

CV6 Therapeutics

Karl Mulligan, PhD, has over 20 years experience in cancer research and the commercial life sciences sector. Since October 2014 he has held the position of Chief Operating Officer and Co-Founder of CV6 Therapeutics (NI) Ltd, an early stage drug development company. In addition he is an Entrepreneur in residence at the Northern Ireland Science […]

Comments Off on Karl A. Mulligan

Robert D. Ladner

CV6 Therapeutics

Robert D. Ladner, PhD was appointed to the post of Reader in the School of Medicine, Dentistry and Biomedical Sciences at Queen’s University Belfast in 2015. Dr. Ladner was awarded his MSc and PhD from Rutgers University/The University of Medicine and Dentistry New Jersey, where he performed his graduate research. It was during this time […]

Comments Off on Robert D. Ladner